Ranked #8,038 of 8,699 institutional investors
Pfizer Inc
New York, NY
$103M
US stock portfolio at live prices · today +$813K (+0.80%)
Market closed. Prices as of Nov 20, 6:11 AM ET
- Value at quarter end (Q3 2026)
- $164M
- Change from Q2 2026
- −$6.1M (−3.59%)
- Positions
- 15 · 1 new, 0 sold out
- Filed
- Nov 12, 2026
Not counted in the ranking: none$8.7M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesARVN 22.7%CELC 16.2%ALLO 14.3%AGMB 11.8%PYXS 11.5%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| ARVN Arvinas, Inc. | 3,457,815 | $23.3M | 22.7% | Unchanged |
| CELC Celcuity Inc. | 295,652 | $16.6M | 16.2% | Unchanged |
| ALLO Allogene Therapeutics, Inc. | 22,032,040 | $14.7M | 14.3% | Unchanged |
| AGMB AgomAb Therapeutics NV | 2,151,213 | $12.1M | 11.8% | Added +2,768% |
| PYXS Pyxis Oncology, Inc. | 7,032,770 | $11.8M | 11.5% | Unchanged |
| WVE Wave Life Sciences, Inc. | 1,875,000 | $5.1M | 4.97% | Unchanged |
| ORIC ORIC Pharmaceuticals, Inc. | 372,904 | $2.9M | 2.80% | Unchanged |
| CRDF Cardiff Oncology, Inc. | 2,411,575 | $2.2M | 2.10% | Unchanged |
| SPRO Spero Therapeutics, Inc. | 2,362,348 | $2.0M | 1.90% | Unchanged |
| CRBU Caribou Biosciences, Inc. | 4,690,431 | $1.5M | 1.42% | Unchanged |
| ZNTL Zentalis Pharmaceuticals, Inc. | 953,834 | $1.3M | 1.26% | Unchanged |
| NXTC NextCure, Inc. | 44,357 | $301K | 0.29% | Unchanged |
| BOLT Bolt Biotherapeutics, Inc. | 31,305 | $158K | 0.15% | Unchanged |
| DNA Ginkgo Bioworks Holdings, Inc. | 2,928 | $24K | <0.1% | Unchanged |
| SENS Senseonics Holdings, Inc. | 2,171 | $19K | <0.1% | New |